Centiva Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,863
Closed -$211K 1384
2023
Q1
$211K Buy
+2,863
New +$211K 0.01% 840